Literature DB >> 1725677

Bone metastases as the first manifestation of a tumour.

M G Barón1, I de la Gándara, E Espinosa, M L de Paredes, P Zamora, J L Mondéjar.   

Abstract

We have reviewed 29 patients whose first sign of a tumour was a bone metastasis. Two primaries were identified, lung adenocarcinoma and uterine adenocarcinoma and in 2 cases a presumptive diagnosis of tumours of the breast and prostate was made. The mean survival time was 3 months. When bone metastases are found in the absence of a primary tumour, investigation must include a clinical history, physical examination, routine laboratory tests and chest radiographs. Mammography should be done in women, particularly when there are palpable axillary nodes. Abdominal CT scanning and bronchoscopy should only be undertaken when there is a clinical indication.

Entities:  

Mesh:

Year:  1991        PMID: 1725677     DOI: 10.1007/bf00186882

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  10 in total

1.  [Yield of diagnostic tests in neoplasms of unknown origin. A retrospective study].

Authors:  M Gil Gil; C Vadell Nadal; X Fabregat Mayol; I Tusquets Trias de Bes; M Nogué Aliguer
Journal:  Rev Clin Esp       Date:  1990-04       Impact factor: 1.556

2.  Identifying the primary site in metastatic cancer of unknown origin. Inadequacy of roentgenographic procedures.

Authors:  J S Nystrom; J M Weiner; R M Wolf; J R Bateman; M V Viola
Journal:  JAMA       Date:  1979-01-26       Impact factor: 56.272

3.  Computed tomography in search of cancer of unknown origin.

Authors:  P R Karsell; P F Sheedy; M J O'Connell
Journal:  JAMA       Date:  1982-07-16       Impact factor: 56.272

Review 4.  The CUP syndrome (carcinoma unknown primary).

Authors:  M J Nissenblatt
Journal:  Cancer Treat Rev       Date:  1981-12       Impact factor: 12.111

5.  The search for the primary tumor in patients with skeletal metastases of unknown origin.

Authors:  M A Simon; E J Bartucci
Journal:  Cancer       Date:  1986-09-01       Impact factor: 6.860

6.  Carcinoma of unknown primary: identification of a treatable subset?

Authors:  A van der Gaast; J Verweij; S C Henzen-Logmans; C J Rodenburg; G Stoter
Journal:  Ann Oncol       Date:  1990       Impact factor: 32.976

7.  [Carcinoma of unknown origin. Diagnostic study of 48 cases and its clinical yield].

Authors:  J Romeu; A Texidó; R Rosell; A Abad-Esteve; R Solans; J Carles
Journal:  Med Clin (Barc)       Date:  1989-02-18       Impact factor: 1.725

8.  Computed tomography in the evaluation of metastatic adenocarcinoma from an unknown primary site. A retrospective study.

Authors:  J H McMillan; E Levine; R H Stephens
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

9.  Comparison of ultrasound and computed tomography in the detection of pancreatic malignancy.

Authors:  P D Kamin; M E Bernardino; S Wallace; B S Jing
Journal:  Cancer       Date:  1980-12-01       Impact factor: 6.860

10.  Adenocarcinoma of unknown primary site. The Brooke Army Medical Center experience.

Authors:  W E Jordan; R A Shildt
Journal:  Cancer       Date:  1985-02-15       Impact factor: 6.860

  10 in total
  4 in total

1.  Features of Spinal Metastases: A Retrospective View.

Authors:  Koray Başdelioğlu
Journal:  Int J Spine Surg       Date:  2021-02-12

2.  Skeletal Metastasis of Unknown Primary Origin at the Initial Visit: A Retrospective Analysis of 286 Cases.

Authors:  Tatsuya Takagi; Hirohisa Katagiri; Yongji Kim; Yoshiyuki Suehara; Daisuke Kubota; Keisuke Akaike; Midori Ishii; Kenta Mukaihara; Taketo Okubo; Hideki Murata; Mitsuru Takahashi; Kazuo Kaneko; Tsuyoshi Saito
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

3.  Non-spine bone metastasis as an initial manifestation of cancer in Korea.

Authors:  Wanlim Kim; Ilkyu Han; Seungcheol Kang; Sang A Lee; Han-Soo Kim
Journal:  J Korean Med Sci       Date:  2014-02-27       Impact factor: 2.153

4.  Role of 18F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis.

Authors:  Soo Bin Park; Jung Mi Park; Seung Hwan Moon; Young Seok Cho; Jong-Mu Sun; Byung-Tae Kim; Kyung-Han Lee
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.